Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000555 · ClinicalTrials.gov registry record · Phase 4
Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)
A Phase 4 study, sponsored by University of South Florida.
- Terminated
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT04000555 is a Phase 4 study that was terminated before completion, run by University of South Florida. The registered enrollment target is 26 participants.
The verdict
NCT04000555, a Phase 4 study, was terminated before completion, sponsored by University of South Florida.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to gain further knowledge regarding the effectiveness of vancomycin prophylaxis in preventing Clostridium difficile infections in order to guide physicians' practices.
Interventions
- OTHER Placebo
- DRUG Oral Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2022-06-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04000555
The ClinicalTrials.gov registry entry for NCT04000555 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04000555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04000555 about?
NCT04000555 is a clinical study titled "Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)". The purpose of this study is to gain further knowledge regarding the effectiveness of vancomycin prophylaxis in preventing Clostridium difficile infections in order to guide physicians' practices.
What is the current status of trial NCT04000555?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2019-09-01. Estimated completion is 2022-06-11.
What interventions are being tested in trial NCT04000555?
The interventions under investigation include: Placebo (OTHER), Oral Vancomycin (DRUG).
Who is sponsoring clinical trial NCT04000555?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.